Triochem Products
17.40
0.00(0.00%)
Market Cap₹0.40 Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D0.00%
1M0.00%
6M0.00%
1Y0.00%
5Y0.00%
View Company Insightsright
More news about Triochem Products
18Aug 25
Triochem Products Reports Widened Q1 Net Loss of Rs. 15.24 Crore
Triochem Products Limited reported a net loss of Rs. 15.24 crore for Q1, a 58.42% increase from the previous year's Q1 loss of Rs. 9.62 crore. Total income remained relatively stable at Rs. 22.10 crore, down 3.79% year-on-year. Despite the net loss, the company reported a total comprehensive income of Rs. 89.27 crore. The Q1 EPS was negative Rs. 1.25, an improvement from the previous quarter's negative Rs. 18.44. The Board approved these unaudited financial results on August 14, prepared in accordance with Indian Accounting Standards.
 no imag found
Triochem Products
17.40
0.0
(0.0%)
1 Year Returns:0.00%
Industry Peers
Sun Pharmaceutical
1,697.50
(-1.01%)
Divis Laboratories
6,168.50
(-0.27%)
Torrent Pharmaceuticals
4,078.00
(+0.02%)
Cipla
1,331.50
(+0.11%)
Dr Reddys Laboratories
1,268.10
(-0.53%)
Lupin
2,199.30
(-0.53%)
Zydus Life Science
904.70
(-1.76%)
Mankind Pharma
2,060.50
(-0.89%)
Aurobindo Pharma
1,145.60
(-1.06%)
Alkem Laboratories
5,402.50
(-7.97%)